Prime Medicine (PRME) Net Margin (2024 - 2026)

Prime Medicine (PRME) posted Net Margin of 5738.55% for Q1 2026, down 4.36% on a QoQ basis from 5498.69% in Q4 2025, and down 216978.0% year-over-year from N/an in Q1 2025.

Prime Medicine (PRME) Net Margin (2024 - 2026) Analysis & Trends

Prime Medicine's Net Margin history runs 3 years deep, the most recent figure standing at 5738.55% for Q1 2026.

  • Quarterly Net Margin fell 216978.0% year-over-year to 5738.55% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4917.55% (up 33495.0% YoY) and the FY2025 annual result came in at 4342.44%, up 222417.0% from the prior year.
  • Net Margin was 5738.55% for Q1 2026 at Prime Medicine, down from 5498.69% in the prior quarter.
  • Across five years, Net Margin topped out at 1936.6% in Q4 2024 and bottomed at 25128.23% in Q3 2024.
  • A 3-year average of 7307.46% and a median of 5107.68% in 2025 frame the typical range for Net Margin.
  • Peak annual rise in Net Margin reached 2099909 bps in 2025, while the deepest fall reached 356209 bps in 2025.
  • Prime Medicine's Net Margin stood at 1936.6% in 2024, then tumbled by 184 bps to 5498.69% in 2025, then fell by 4 bps to 5738.55% in 2026.
  • Business Quant data shows PRME's Net Margin at 5738.55% in Q1 2026, 5498.69% in Q4 2025, and 4129.14% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Prime Medicine 525.98 Mn 525.98 Mn - -5,738.55%

Historic Data

Download Data
DateValue
Mar 31, 2026 -5,738.55%
Dec 31, 2025 -5,498.69%
Sep 30, 2025 -4,129.14%
Jun 30, 2025 -4,716.68%
Mar 31, 2025 -3,568.78%
Dec 31, 2024 -1,936.60%
Sep 30, 2024 -25,128.23%
Mar 31, 2024 -7,742.98%